These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3145 related articles for article (PubMed ID: 7524891)

  • 1. Bioactive Arg-Gly-Asp conformations in anti-integrin GPIIb-IIIa antibodies.
    Prammer KV; Boyer J; Ugen K; Shattil SJ; Kieber-Emmons T
    Receptor; 1994; 4(2):93-108. PubMed ID: 7524891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular model of RGD ligands. Antibody D gene segments that direct specificity for the integrin alpha IIb beta 3.
    Tomiyama Y; Brojer E; Ruggeri ZM; Shattil SJ; Smiltneck J; Gorski J; Kumar A; Kieber-Emmons T; Kunicki TJ
    J Biol Chem; 1992 Sep; 267(25):18085-92. PubMed ID: 1517241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-GPIIb/IIIa antibodies: powerful tools to investigate function and regulation of an integrin.
    Bachelot C; Rendu F; Gulino D
    Semin Thromb Hemost; 1995; 21(1):23-36. PubMed ID: 7541559
    [No Abstract]   [Full Text] [Related]  

  • 4. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa.
    Fisher MJ; Gunn B; Harms CS; Kline AD; Mullaney JT; Nunes A; Scarborough RM; Arfsten AE; Skelton MA; Um SL; Utterback BG; Jakubowski JA
    J Med Chem; 1997 Jun; 40(13):2085-101. PubMed ID: 9207949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site.
    Barbas CF; Languino LR; Smith JW
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10003-7. PubMed ID: 7694276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin alpha(IIb)beta(3).
    Puzon-McLaughlin W; Kamata T; Takada Y
    J Biol Chem; 2000 Mar; 275(11):7795-802. PubMed ID: 10713093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.
    Müller G; Gurrath M; Kessler H
    J Comput Aided Mol Des; 1994 Dec; 8(6):709-30. PubMed ID: 7738606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex.
    Calvete JJ
    Thromb Haemost; 1994 Jul; 72(1):1-15. PubMed ID: 7974356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the OPG2 Fab. An antireceptor antibody that mimics an RGD cell adhesion site.
    Kodandapani R; Veerapandian B; Kunicki TJ; Ely KR
    J Biol Chem; 1995 Feb; 270(5):2268-73. PubMed ID: 7836460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers.
    Frelinger AL; Cohen I; Plow EF; Smith MA; Roberts J; Lam SC; Ginsberg MH
    J Biol Chem; 1990 Apr; 265(11):6346-52. PubMed ID: 2318856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis and modeling of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme.
    Yamada T; Uyeda A; Kidera A; Kikuchi M
    Biochemistry; 1994 Oct; 33(39):11678-83. PubMed ID: 7522552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis.
    Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH
    J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin alphaIIbbeta3-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation.
    Chung J; Rader C; Popkov M; Hur YM; Kim HK; Lee YJ; Barbas CF
    FASEB J; 2004 Feb; 18(2):361-3. PubMed ID: 14688205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor.
    Satoh T; Kouns WC; Yamashita Y; Kamiyama T; Steiner B
    Biochem Biophys Res Commun; 1994 Oct; 204(1):325-32. PubMed ID: 7524499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of molecular shape with GPIIb-IIIa receptor antagonist activity in RGD peptides.
    Tung JS; Jakubowski JA; Heath WF; Utterback BG; Herron DK
    Receptor; 1993; 3(4):343-56. PubMed ID: 8142908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine mapping of inhibitory anti-alpha5 monoclonal antibody epitopes that differentially affect integrin-ligand binding.
    Burrows L; Clark K; Mould AP; Humphries MJ
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):527-33. PubMed ID: 10567237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand interactions with the RGD recognition site alter binding of GPIIb-IIIa reactive monoclonal antibody to human platelets.
    Marder P
    Biochem Biophys Res Commun; 1993 Sep; 195(2):799-806. PubMed ID: 8373415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI.
    Pfaff M; Aumailley M; Specks U; Knolle J; Zerwes HG; Timpl R
    Exp Cell Res; 1993 May; 206(1):167-76. PubMed ID: 8387021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 158.